NCT06493409View on ClinicalTrials.gov

A Study to Assess the Effect of Voriconazole and Quinidine on the Pharmacokinetics of a Single Dose of Repotrectinib in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

August 26, 2024

Primary Completion Date

December 7, 2024

Study Completion Date

December 7, 2024

Conditions
Healthy Volunteers
Interventions
DRUG

Repotrectinib

Specified dose on specified days

DRUG

Voriconazole

Specified dose on specified days

DRUG

Quinidine

Specified dose on specified days

Trial Locations (1)

32117

Fortrea - Daytona Beach, Daytona Beach

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT06493409 - A Study to Assess the Effect of Voriconazole and Quinidine on the Pharmacokinetics of a Single Dose of Repotrectinib in Healthy Participants | Biotech Hunter | Biotech Hunter